← Leaderboards
Peter Anthony Crooks
University Of Kentucky
$3,110,679
Attributed
$3,110,679
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $326.5K · FY2011–20$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,110,679 · 2
By mechanism
P01$1,559,090 · 1
R01$1,551,589 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- William H St Clair$3,066,919
- Daret K St Clair$20,807,410
- Larry W Robertson$23,194,141
- Royce Mohan$8,216,905
- Audra L Stinchcomb$9,682,621
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseBiologicalIn VivoDrug KineticsMolecularLeadTherapeutic AgentsModificationPharmaceutical PreparationsStructurePre-ClinicalPlasmaDesignAnalogProdrugsLeukemiaBasic ScienceAbsorptionBackAnimal ModelBoneBuffersBloodBiotin
Grant awards (11)
Core D: Drug Discovery$311,818
P01 · FY2020 · AG · contact PI
Core D: Drug Discovery$311,818
P01 · FY2019 · AG · contact PI
Core D: Drug Discovery$311,818
P01 · FY2018 · AG · contact PI
Core D: Drug Discovery$311,818
P01 · FY2017 · AG · contact PI
Core D: Drug Discovery$311,818
P01 · FY2016 · AG · contact PI
Novel melampomagnolide B-based prodrugs for the treatment of leukemia$313,325
R01 · FY2015 · CA · contact PI
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???$303,926
R01 · FY2014 · CA · contact PI
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???$294,525
R01 · FY2013 · CA · contact PI
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???$313,325
R01 · FY2012 · CA · contact PI
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???$324,557
R01 · FY2011 · CA · contact PI
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???$1,931
R01 · FY2011 · CA · contact PI